المؤلفون: Alonso FH; Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California, Davis, Davis, CA, United States.; Department of Biomedical Sciences, Ross University School of Veterinary Medicine, Basseterre, Saint Kitts and Nevis., Niedringhaus KD; Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California, Davis, Davis, CA, United States., Ceregatti MG; Department of Veterinary Clinic and Surgery, School of Veterinary Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil., Maglaty MA; Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California, Davis, Davis, CA, United States.

المصدر: Frontiers in veterinary science [Front Vet Sci] 2022 Jul 18; Vol. 9, pp. 934009. Date of Electronic Publication: 2022 Jul 18 (Print Publication: 2022).

نوع المنشور: Case Reports

بيانات الدورية: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101666658 Publication Model: eCollection Cited Medium: Print ISSN: 2297-1769 (Print) Linking ISSN: 22971769 NLM ISO Abbreviation: Front Vet Sci Subsets: PubMed not MEDLINE

المؤلفون: Patel NR; a Nemucore Medical Innovations, Inc. , Wellesley , MA., Piroyan A; a Nemucore Medical Innovations, Inc. , Wellesley , MA., Ganta S; a Nemucore Medical Innovations, Inc. , Wellesley , MA., Morse AB; a Nemucore Medical Innovations, Inc. , Wellesley , MA., Candiloro KM; a Nemucore Medical Innovations, Inc. , Wellesley , MA., Solon AL; a Nemucore Medical Innovations, Inc. , Wellesley , MA., Nack AH; a Nemucore Medical Innovations, Inc. , Wellesley , MA., Galati CA; a Nemucore Medical Innovations, Inc. , Wellesley , MA., Bora C; a Nemucore Medical Innovations, Inc. , Wellesley , MA., Maglaty MA; b Molecular Therapeutics Program, Fox Chase Cancer Center , 333 Cottman Avenue, Philadelphia , PA., O'Brien SW; b Molecular Therapeutics Program, Fox Chase Cancer Center , 333 Cottman Avenue, Philadelphia , PA., Litwin S; b Molecular Therapeutics Program, Fox Chase Cancer Center , 333 Cottman Avenue, Philadelphia , PA.; c Biostatistics Facility, Fox Chase Cancer Center , 333 Cottman Avenue, Philadelphia , PA., Davis B; a Nemucore Medical Innovations, Inc. , Wellesley , MA., Connolly DC; b Molecular Therapeutics Program, Fox Chase Cancer Center , 333 Cottman Avenue, Philadelphia , PA., Coleman TP; a Nemucore Medical Innovations, Inc. , Wellesley , MA.

المصدر: Cancer biology & therapy [Cancer Biol Ther] 2018 Jul 03; Vol. 19 (7), pp. 554-564. Date of Electronic Publication: 2018 May 08.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101137842 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1555-8576 (Electronic) Linking ISSN: 15384047 NLM ISO Abbreviation: Cancer Biol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*administration & dosage , Docetaxel/*administration & dosage , Drug Carriers/*chemistry , Folate Receptor 1/*metabolism , Ovarian Neoplasms/*drug therapy, Animals ; Antineoplastic Agents/pharmacokinetics ; Cell Line, Tumor ; Disease Models, Animal ; Docetaxel/pharmacokinetics ; Drug Carriers/pharmacology ; Emulsions ; Endocytosis ; Female ; Folic Acid/metabolism ; Gadolinium/chemistry ; Gadolinium/pharmacology ; Humans ; Magnetic Resonance Imaging/methods ; Mice ; Mice, Inbred C57BL ; Mice, Transgenic ; Molecular Imaging/methods ; Nanoparticles/chemistry ; Neoplasm Recurrence, Local ; Ovarian Neoplasms/diagnostic imaging ; Ovarian Neoplasms/genetics ; Ovarian Neoplasms/pathology ; Theranostic Nanomedicine/methods

المؤلفون: Gritsina G; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Xiao F; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania., O'Brien SW; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Gabbasov R; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania. Kazan (Volga Region) Federal University, Kazan, Russia., Maglaty MA; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Xu RH; Immune Cell Development and Host Defense Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Thapa RJ; Immune Cell Development and Host Defense Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Zhou Y; Biostatistics Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Nicolas E; Genomics Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Litwin S; Biostatistics Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Balachandran S; Immune Cell Development and Host Defense Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Sigal LJ; Immune Cell Development and Host Defense Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Huszar D; AstraZeneca Oncology iMed, Waltham, Massachusetts., Connolly DC; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania. Denise.Connolly@fccc.edu.

المصدر: Molecular cancer therapeutics [Mol Cancer Ther] 2015 Apr; Vol. 14 (4), pp. 1035-47. Date of Electronic Publication: 2015 Feb 02.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE

مواضيع طبية MeSH: Analgesics/*pharmacology , Janus Kinases/*metabolism , Ovarian Neoplasms/*metabolism , STAT3 Transcription Factor/*metabolism , Signal Transduction/*drug effects, Analgesics/administration & dosage ; Animals ; Apoptosis/drug effects ; Cell Line, Tumor ; Cell Movement/drug effects ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Cluster Analysis ; Disease Models, Animal ; Female ; Gene Expression ; Gene Expression Profiling ; Humans ; Integrin alphaVbeta3/genetics ; Integrin alphaVbeta3/metabolism ; Matrix Metalloproteinases/metabolism ; Mice ; Mice, Transgenic ; Ovarian Neoplasms/diagnosis ; Ovarian Neoplasms/drug therapy ; Ovarian Neoplasms/genetics ; Ovarian Neoplasms/pathology ; Pyrazoles/administration & dosage ; Pyrazoles/pharmacology ; Pyrimidines/administration & dosage ; Pyrimidines/pharmacology ; Xenograft Model Antitumor Assays

المؤلفون: Liu H; Authors' Affiliations: Developmental Therapeutics Program, Biostatistics Facility, Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania; and Synta Pharmaceuticals Corp., Lexington, Massachusetts., Xiao F, Serebriiskii IG, O'Brien SW, Maglaty MA, Astsaturov I, Litwin S, Martin LP, Proia DA, Golemis EA, Connolly DC

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2013 Sep 15; Vol. 19 (18), pp. 5053-67. Date of Electronic Publication: 2013 Jul 30.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Apoptosis/*drug effects , Cell Cycle/*drug effects , Cell Proliferation/*drug effects , Gene Regulatory Networks/*drug effects , HSP90 Heat-Shock Proteins/*antagonists & inhibitors , Ovarian Neoplasms/*metabolism, Animals ; Antineoplastic Agents, Phytogenic/pharmacology ; Blotting, Western ; Drug Synergism ; Drug Therapy, Combination ; Female ; Flow Cytometry ; HSP90 Heat-Shock Proteins/genetics ; HSP90 Heat-Shock Proteins/metabolism ; Humans ; Mice ; Mice, SCID ; Mice, Transgenic ; Ovarian Neoplasms/drug therapy ; Ovarian Neoplasms/genetics ; Paclitaxel/pharmacology ; Protein Array Analysis ; RNA, Small Interfering/genetics ; Triazoles/pharmacology ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays